Floating Button
Home Capital Broker's Calls

Downside risks for US office SREITs limited in near-term despite Coivd-19 outbreak

Samantha Chiew
Samantha Chiew • 2 min read
Downside risks for US office SREITs limited in near-term despite Coivd-19 outbreak
DBS has 'buy' calls on all 3 US office SREITs, as near-term risks are still limited
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Mar 20): DBS Group Research has “buy” calls on all three US office Singapore REITs. It has target prices of $1.15 on Manulife US REIT, $1.05 on Prime US REIT and 90 cents on Keppel Pacific Oak US REIT.

Following the recent development of the Covid-19 spreading to North America and Europe that could tip these economies into a recession, the share price of US Office SREITs has taken a big hit, falling off a cliff by 47%-50% from its peak only in January this year.

At current prices, US Office SREITs are now trading at 11% to 16% yield and 0.5 time to 0.7 time price-to-book.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.